India Cancer Treatment Drugs Market Research Report: Forecast (2025-2030)

India Cancer Treatment Drugs Market Report - By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Other Treatment Types), By Drug Class (Cytotoxic...... Drugs, [Alkylating Agents, Antimetabolites, Others], Targeted Drugs, [Monoclonal Antibodies, Others], Hormonal Drugs, Others), By Type (Blood Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Non-Hodgkin’s Cancer, Respiratory/ Lung Cancer, Stomach Cancer, Other Cancers), By Dosage Form (Solid, [Tablets, Capsules], Liquid, Injectable, Prefilled Syringes, Others), By End-Users (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and others Read more

  • Healthcare
  • Mar 2023
  • 132
  • PDF, Excel, PPT

Market Insights & Analysis: India Cancer Treatment Drugs Market (2025-30)

The India Cancer Treatment Drugs Market is projected to grow at a CAGR of around 12.2% during the forecast period, i.e., 2025-30. With estimated 1.39 million cancer cases in 2020, the disease has become a public health concern in India. Earlier, the total number of deaths from cancer in India was more than 0.8 million in 2019. It is estimated that one woman dies of cervical cancer every 8 minutes in India due to cancer, according to the National Institute of Cancer Prevention and Research. Of every two women newly diagnosed with breast cancer, one dies of it in India. Moreover, tobacco consumption in the country is burgeoning, thereby mounting the total number of deaths from tobacco cancer.

Continuous growth in cancer cases owing to changing eating habits, food adulteration, environmental changes, growth in chemical establishments, etc., are the major factors for escalating cancer cases in India. Other than these, the sedentary lifestyle and excessive intake of junk food have led to an increase in cancer patients over the past few years. As a result, the need for timely diagnosis and preventive care is surging at an exponential pace, leading to extensive investments in R&D, thereby setting the stage for medicine manufacturers to come up with more effective drugs to address such escalation in the country. Additionally, India has witnessed remarkable opportunities for venture capitalists and investors, as the developed markets are comparatively saturated in this industry.

Report Coverage Details
  Historical Years   2020-23
  Base Years
  2024
  Forecast Years
  2025-30
  CAGR (2025-30)   12.2%
  Top Key Players Amgen, Astellas Pharma Inc., AstraZeneca , Bayer, Bristol-Myers Squibb Company, Cipla, F. Hoffmann- La- Roche, Merck KGaA, Natco Pharma, Novartis AG, Pfizer
  Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation,
  • Recent Strategic Moves by Companies,
  • Primary Stakeholders,
  • Analysis of Import and Export Trends,
  • Competitive Landscape Assessment,
  • Emerging Opportunities,
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Further, expanding focus on oncology in All India Institute of Medical Sciences (AIIMS) and effective diagnosis and treatment of cancer under the Ayushman Bharat Scheme is likely to boost the sales of cancer treatment drugs. Furthermore, ever-improved cancer care infrastructure with upgraded facilities for tertiary care in recent years has positively influenced the industry with exploding need for effective medicines. Primarily in the states of Madhya Pradesh, Odisha, Assam, Uttarakhand, Himachal Pradesh, Punjab, Haryana, Delhi, Maharashtra, Karnataka, etc., where the cases are quite prominent, with the major prevalence of lip, oral, breast, and cervical cancer. Thus, requiring the drugs related to these types of cancers and accelerating their manufacturing in the forecast period, thus aiding in enhancing the India Cancer Treatment Drugs Market size.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. India Cancer Treatment Drugs Market Policies, Regulations, and Product Standards
  5. India Cancer Treatment Drugs Market Trends & Developments
  6. India Cancer Treatment Drugs Market Dynamics
    1. Growth Drivers
    2. Challenges
  7. India Cancer Treatment Drugs Market Hotspot & Opportunities
  8. India Cancer Treatment Drugs Market Value Chain Analysis
  9. India Cancer Treatment Drugs Market Outlook, 2020-2030F
    1. Market Size & Outlook
      1. By Revenue (USD Million)
    2. Market Share & Outlook
      1. By Treatment Type
        1. Chemotherapy- Market Size & Forecast 2020-2030, USD Million
        2. Targeted Therapy- Market Size & Forecast 2020-2030, USD Million
        3. Immunotherapy- Market Size & Forecast 2020-2030, USD Million
        4. Hormonal Therapy- Market Size & Forecast 2020-2030, USD Million
        5. Other Treatment Types- Market Size & Forecast 2020-2030, USD Million   
    3. By Drug Class
      1. Cytotoxic Drugs- Market Size & Forecast 2020-2030, USD Million
        1. Alkylating Agents- Market Size & Forecast 2020-2030, USD Million
        2. Antimetabolites- Market Size & Forecast 2020-2030, USD Million
        3. Others- Market Size & Forecast 2020-2030, USD Million
      2. Targeted Drugs- Market Size & Forecast 2020-2030, USD Million
        1. Monoclonal Antibodies- Market Size & Forecast 2020-2030, USD Million
        2. Others- Market Size & Forecast 2020-2030, USD Million
      3. Hormonal Drugs- Market Size & Forecast 2020-2030, USD Million
      4. Others- Market Size & Forecast 2020-2030, USD Million
    4. By Type
      1. Blood Cancer- Market Size & Forecast 2020-2030, USD Million
      2. Breast Cancer- Market Size & Forecast 2020-2030, USD Million
      3. Colorectal Cancer- Market Size & Forecast 2020-2030, USD Million
      4. Cervical Cancer- Market Size & Forecast 2020-2030, USD Million
      5. Prostate Cancer- Market Size & Forecast 2020-2030, USD Million
      6. Gastrointestinal Cancer- Market Size & Forecast 2020-2030, USD Million
      7. Gynecologic Cancer- Market Size & Forecast 2020-2030, USD Million
      8. Non-Hodgkin’s Cancer- Market Size & Forecast 2020-2030, USD Million
      9. Respiratory/ Lung Cancer- Market Size & Forecast 2020-2030, USD Million
      10. Stomach Cancer- Market Size & Forecast 2020-2030, USD Million
      11. Other Cancers- Market Size & Forecast 2020-2030, USD Million
    5. By Dosage Form
      1. Solid- Market Size & Forecast 2020-2030, USD Million
        1. Tablets- Market Size & Forecast 2020-2030, USD Million
        2. Capsules- Market Size & Forecast 2020-2030, USD Million
      2. Liquid- Market Size & Forecast 2020-2030, USD Million
      3. Injectable- Market Size & Forecast 2020-2030, USD Million
        1. Prefilled Syringes- Market Size & Forecast 2020-2030, USD Million
        2. Others- Market Size & Forecast 2020-2030, USD Million
    6. By End-Users
      1. Hospitals- Market Size & Forecast 2020-2030, USD Million
      2. Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
      3. Cancer and Radiation Therapy Centers- Market Size & Forecast 2020-2030, USD Million
    7. By Distribution Channel
      1. Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
      2. Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
      3. Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
    8. By Region
      1. North
      2. South
      3. East
      4. West
    9. By Company
      1. Company Revenue Shares
      2. Competitor Characteristics
  10. India Chemotherapy Cancer Treatment Drugs Market Outlook, 2020-2030F
    1. Market Size & Outlook
      1. By Revenue (USD Million)
    2. Market Share & Outlook
      1. By Drug Class- Market Size & Forecast 2020-2030, USD Million
      2. By Type- Market Size & Forecast 2020-2030, USD Million
      3. By End-Users- Market Size & Forecast 2020-2030, USD Million
  11. India Targeted Therapy Cancer Treatment Drugs Market Outlook, 2020-2030F
    1. Market Size & Outlook
      1. By Revenue (USD Million)
    2. Market Share & Outlook
      1. By Drug Class- Market Size & Forecast 2020-2030, USD Million
      2. By Type- Market Size & Forecast 2020-2030, USD Million
      3. By End-Users- Market Size & Forecast 2020-2030, USD Million
  12. India Immunotherapy Cancer Treatment Drugs Market Outlook, 2020-2030F
    1. Market Size & Outlook
      1. By Revenue (USD Million)
    2. Market Share & Outlook
      1. By Drug Class- Market Size & Forecast 2020-2030, USD Million
      2. By Type- Market Size & Forecast 2020-2030, USD Million
      3. By End-Users- Market Size & Forecast 2020-2030, USD Million
  13. India Hormonal Therapy Cancer Treatment Drugs Market Outlook, 2020-2030F
    1. Market Size & Outlook
      1. By Revenue (USD Million)
    2. Market Share & Outlook
      1. By Drug Class- Market Size & Forecast 2020-2030, USD Million
      2. By Type- Market Size & Forecast 2020-2030, USD Million
      3. By End-Users- Market Size & Forecast 2020-2030, USD Million
  14. India Cancer Treatment Drugs Market Key Strategic Imperatives for Success & Growth
  15. Competition Outlook
    1. Company Profiles
      1. Amgen
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Astellas Pharma Inc.
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. AstraZeneca
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Bayer
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Bristol-Myers Squibb Company
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Cipla
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. F. Hoffmann- La- Roche
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Merck KGaA
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Natco Pharma
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Novartis AG
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Others
  16. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying Inquire Before Buying
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization